19809

0

MAITREYA

img img img img
No Data Available

MAITREYA MEDICARE LIMITED Share Price Update

As of the latest trading session, MAITREYA MEDICARE LIMITED share price is currently at ₹207.75, which is up by ₹6.39 from its previous closing. Today, the stock has fluctuated between ₹193.30 and ₹207.75. Over the past year, MAITREYA MEDICARE LIMITED has achieved a return of -31.35%. In the last month alone, the return has been -2.70%.

MAITREYA MEDICARE LIMITED performance

Today’s low

Today’s high

₹ 193.30 ₹ 207.75
₹ 201.35

52 week low

52 week high

₹ 186.00 ₹ 329.00
₹ 201.35

Open Price

₹ 193.30

Prev. Close

₹ 201.35

Volume (Shares)

1200.00

Total traded value

₹ 2.41

Upper Circuit

₹ 241.60

Lower Circuit

₹ 161.10

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MAITREYA MEDICARE LIMITED fundamentals


  • Market cap (Cr)

    136.40

  • P/E Ratio (TTM)

    71.91

  • Beta

    0.18

  • Book Value / share

    39.49

  • Return on equity

    7.36%

  • EPS (TTM)

    2.78

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -0.89

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

MAITREYA MEDICARE LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 10.60
Operating Expense 11.96
Net Profit -0.89
Net Profit Margin (%) -8.39
Earnings Per Share (EPS) -1.34
EBITDA -0.63
Effective Tax Rate (%) 24.57
Particulars DEC 2023 (Values in Cr)
Revenue 11.65
Operating Expense 9.53
Net Profit 1.60
Net Profit Margin (%) 13.73
Earnings Per Share (EPS) 2.88
EBITDA 2.55
Effective Tax Rate (%) 24.64
Particulars SEP 2023 (Values in Cr)
Revenue 13.53
Operating Expense 11.21
Net Profit 1.84
Net Profit Margin (%) 13.59
Earnings Per Share (EPS) 3.53
EBITDA 2.81
Effective Tax Rate (%) 22.36
Particulars JUN 2023 (Values in Cr)
Revenue 10.75
Operating Expense 0.00
Net Profit 0.61
Net Profit Margin (%) 5.67
Earnings Per Share (EPS) 1.24
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 10.50
Operating Expense 8.22
Net Profit 1.79
Net Profit Margin (%) 17.04
Earnings Per Share (EPS) 2.69
EBITDA 3.07
Effective Tax Rate (%) 31.15
Particulars MAR 2025 (Values in Cr)
Revenue 44.41
Operating Expense 41.63
Net Profit 1.90
Net Profit Margin (%) 4.27
Earnings Per Share (EPS) 2.80
EBITDA 5.32
Effective Tax Rate (%) 40.99
Particulars MAR 2024 (Values in Cr)
Revenue 46.53
Operating Expense 42.36
Net Profit 3.17
Net Profit Margin (%) 6.81
Earnings Per Share (EPS) 6.65
EBITDA 6.39
Effective Tax Rate (%) 27.56
Particulars MAR 2023 (Values in Cr)
Revenue 38.48
Operating Expense 33.17
Net Profit 3.30
Net Profit Margin (%) 8.57
Earnings Per Share (EPS) 6.65
EBITDA 7.68
Effective Tax Rate (%) 28.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 39.43
ROE % 7.25
ROCE % 10.95
Total Debt to Total Equity 0.18
EBITDA Margin 11.68
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.67
ROE % 15.53
ROCE % 17.87
Total Debt to Total Equity 0.26
EBITDA Margin 13.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.68
ROE % 58.61
ROCE % 34.66
Total Debt to Total Equity 0.55
EBITDA Margin 19.78
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4711.12
ROE % 19.84
ROCE % 13.47
Total Debt to Total Equity 0.90
EBITDA Margin 7.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3862.16
ROE % 103.37
ROCE % 36.13
Total Debt to Total Equity 1.03
EBITDA Margin 13.57
Particulars MAR 2025 (Values in Cr)
Book Value / Share 39.49
ROE % 7.36
ROCE % 11.36
Total Debt to Total Equity 0.12
EBITDA Margin 11.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.69
ROE % 16.71
ROCE % 18.73
Total Debt to Total Equity 0.22
EBITDA Margin 13.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.71
ROE % 54.52
ROCE % 33.53
Total Debt to Total Equity 0.54
EBITDA Margin 19.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5485.40
ROE % 21.70
ROCE % 11.95
Total Debt to Total Equity 0.84
EBITDA Margin 6.99
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4372.60
ROE % 203.70
ROCE % 44.04
Total Debt to Total Equity 1.29
EBITDA Margin 13.77
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.91
Total Assets 47.99
Total Liabilities 47.99
Total Equity 32.85
Share Outstanding 0
Price to Book Ratio 7.74
Return on Assets (%) 3.90
Return on Capital (%) 4.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.55
Total Assets 43.86
Total Liabilities 43.86
Total Equity 30.35
Share Outstanding 0
Price to Book Ratio 3.24
Return on Assets (%) 6.77
Return on Capital (%) 8.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.93
Total Assets 28.91
Total Liabilities 28.91
Total Equity 15.54
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.70
Return on Capital (%) 19.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 24.48
Total Liabilities 24.48
Total Equity 10.87
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.64
Return on Capital (%) 6.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.90
Total Assets 25.27
Total Liabilities 25.27
Total Equity 9.59
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 16.79
Return on Capital (%) 22.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.90
Total Assets 44.41
Total Liabilities 44.41
Total Equity 32.07
Share Outstanding 0
Price to Book Ratio 7.74
Return on Assets (%) 4.27
Return on Capital (%) 5.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.66
Total Assets 40.51
Total Liabilities 40.51
Total Equity 30.25
Share Outstanding 0
Price to Book Ratio 3.24
Return on Assets (%) 7.83
Return on Capital (%) 9.25
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.48
Total Assets 27.74
Total Liabilities 27.74
Total Equity 14.51
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.08
Return on Capital (%) 20.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 22.83
Total Liabilities 22.83
Total Equity 10.36
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.66
Return on Capital (%) 5.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 25.89
Total Liabilities 25.89
Total Equity 9.42
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 17.02
Return on Capital (%) 23.69
Particulars MAR 2025 (Values in Cr)
Net Income 3.21
Cash from Operations 6.52
Cash from Investing -7.37
Cash from Financing 3.67
Net change in Cash 1.35
Free Cash Flow 8.90
Particulars MAR 2024 (Values in Cr)
Net Income 4.15
Cash from Operations -0.73
Cash from Investing -5.43
Cash from Financing 12.20
Net change in Cash 4.26
Free Cash Flow 0.88
Particulars MAR 2023 (Values in Cr)
Net Income 5.95
Cash from Operations 2.90
Cash from Investing 0.36
Cash from Financing -1.58
Net change in Cash 1.36
Free Cash Flow 2.93
Particulars MAR 2022 (Values in Cr)
Net Income 1.59
Cash from Operations 1.80
Cash from Investing -0.01
Cash from Financing -1.86
Net change in Cash -1.80
Free Cash Flow 2.70
Particulars MAR 2021 (Values in Cr)
Net Income 5.77
Cash from Operations 5.60
Cash from Investing -5.06
Cash from Financing 2.16
Net change in Cash 1.54
Free Cash Flow 11.23
Particulars MAR 2025 (Values in Cr)
Net Income 3.22
Cash from Operations 6.48
Cash from Investing -7.20
Cash from Financing -1.57
Net change in Cash -3.75
Free Cash Flow 8.85
Particulars MAR 2024 (Values in Cr)
Net Income 4.38
Cash from Operations 1.51
Cash from Investing -5.56
Cash from Financing 10.00
Net change in Cash 4.17
Free Cash Flow 2.19
Particulars MAR 2023 (Values in Cr)
Net Income 5.87
Cash from Operations 2.72
Cash from Investing 0.35
Cash from Financing -1.33
Net change in Cash 1.43
Free Cash Flow 2.75
Particulars MAR 2022 (Values in Cr)
Net Income 1.41
Cash from Operations 2.00
Cash from Investing 0.16
Cash from Financing -2.61
Net change in Cash -1.67
Free Cash Flow 2.90
Particulars MAR 2021 (Values in Cr)
Net Income 5.97
Cash from Operations 5.12
Cash from Investing -5.62
Cash from Financing 1.51
Net change in Cash 0.78
Free Cash Flow 10.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7611.45 60.25 12.04 109440.97 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 56.05 23.16 3.05 105.05 52.24 / 98.70
SHREE PACETRONIX LTD. 139.80 20.65 3.13 51.37 61.11 / 283.15
TRANSGENE BIOTEK LTD. 2.67 0.00 2.19 20.23 1.83 / 5.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7611.45 75.35 11.74 109440.97 6002.15 / 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.13 0.00 -11.07 28.48 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5371.10 24.92 4.93 5875.98 4810.20 / 6725.00

MAITREYA MEDICARE LIMITED shareholding pattern

Holding

26.88%
73.11%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MAITREYA MEDICARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
201.35 0.00 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 203.70
  • 26 Days 208.60
  • 10 Days 203.90
  • 50 Days 217.30
  • 12 Days 204.30
  • 100 Days 231.10
  • 20 Days 206.50
  • 200 Days 244.30
206.95 PIVOT

First Support

204.95

First Resistance

207.95

Second Support

203.95

Second Resistance

209.95

Third Support

201.95

Third Resistance

210.95

RSI

47.98

ADX

16.13

MACD

-4.36

Williams % R

-52.44

Commodity Channel Index (CCI)

1.43

Date

2026-02-16

Week

1400.00

Same Day

0.00

Month

1318.00

1 Year

0.19

3 Year

0.44

Over 1 Month

-2.70%

down

Over 1 Year

-31.35%

down

Over 3 Months

-26.55%

down

Over 3 Years

11.13%

down

Over 6 Months

-19.02%

down

Over 5 Years

0.00%

down

MAITREYA MEDICARE LIMITED Corporate Actions

Top Gainers

MAITREYA MEDICARE LIMITED Share Price

Maitreya Medicare Limited was originally incorporated as Maitreya Medicare Private Limited' at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC). Thereafter, name of the
Company was changed to Maitreya Medicare Limited' and a fresh Certificate of Incorporation was issued by the RoC on March 30, 2023. Since then, Company engages in providing healthcare services and products.

The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry. The Company is a growing organization that aims at strengthening and establishing itself as foremost healthcare services provider. It has a team of medical practitioners who ensures that patients get the quality healthcare services. The Company's healthcare staff members comprise of Unit Head, Consultant Doctors, Clinical Pharmacist, X-Ray Technician, Medical Officers, Clinical Assistants, Medical Executives, OT Assistant, Infection Control Nurse, Other Nursing Staff, Attendants, Maintenance Head, Dietician /Nutritionist etc. Also, the Company is associated with several organizations' for providing regular healthcare check-up facilities to their employees at affordable rates.

The Company's healthcare facilities consist of advanced technology and our doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards. Company provide inpatient and outpatient healthcare services through its hospitals at Surat, Mumbai, Valsad and Nandurbar (Maharashtra), with an aggregate bed capacity of 550 beds.

In 2019, the Company commissioned their first commercial operations at Surat Hospital, in Gujarat. It expanded for B Wing and converted into 125 beds from 100 beds in 2021.

The Hospital's core specialities are Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.

Their healthcare facilities consist of advanced technology and doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards. The hospital boasts of one of its kind premier Cathlab, two modular superspeciality operation theatres with laminar air flow and HEPA filters, well equipped 20 bedded Intensive Care Units (ICU) with ECMO and CRRT and excellent support services like Pathology and Radiology including CT scan. This unit has the potential to expand further by 75 beds to make it 200 bed structure with quaternary care facilities like Organ Transplants, Robotics in near future.

In November 2023, Company launched the IPO by issuing 18,16,000 equity shares of Rs 10 each and raised a fresh issue of 14.89 crores.

Parent organization Indian Private
NSE symbol MAITREYA
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Maitreya Medicare Ltd?

Answer Field

Maitreya Medicare Ltd share price is for NSE ₹ 207.75 & for BSE ₹ 0.00 as on Feb 17 2026 03:28 PM.

What is the Market Cap of Maitreya Medicare Ltd Share?

Answer Field

The market cap of Maitreya Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Feb 17 2026 03:28 PM.

What is the 52 Week High and Low of Maitreya Medicare Ltd?

Answer Field

The 52 Week High and Low of Maitreya Medicare Ltd for NSE is ₹ 329.00 and ₹ 186.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Maitreya Medicare Ltd?

Answer Field

The 1 year returns on the stock has been -30.65%.

What is the P/E Ratio of Maitreya Medicare Ltd Share?

Answer Field

As on Feb 17 2026 03:28 PM the price-to-earnings (PE) ratio for Maitreya Medicare Ltd share is 71.91.

What is the PB ratio of Maitreya Medicare Ltd Share?

Answer Field

As on Feb 17 2026 03:28 PM, the price-to-book (PB) ratio for Maitreya Medicare Ltd share is 39.49.

How to Buy Maitreya Medicare Ltd Share?

Answer Field

You can trade in Maitreya Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Maitreya Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Maitreya Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Maitreya Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59